Treatment Approach for Short QT Syndrome
Short QT syndrome is a cardiac channelopathy characterised by a pathologically abbreviated QT interval, associated with risk of arrhythmia. Structured management is important to reduce that risk.
Treatment Considerations
Management includes careful review and avoidance of specific medications known to shorten the QT interval — of which one example is identified in the protocol.
The full protocol specifies which drug classes and agents are implicated, and what the complete management pathway covers.
References
- Drugs that shorten QT interval should be avoided, e.g. nicorandil.
- DOI: 10.1093/eurheartj/ehac262
View source ↗